# Real-World Immuno-Radiotherapy for Advanced NSCLC

> **NCT06747026** · — · COMPLETED · sponsor: **Fengming Kong** · enrollment: 338 (actual)

## Conditions studied

- Lung Cancer Non-Small Cell Cancer (NSCLC)

## Interventions

- **DRUG:** initial Sequential iRT
- **DRUG:** initial Concurrent iRT
- **DRUG:** RT with maintenance of ICI
- **DRUG:** RT after discontinuation of ICI

## Key facts

- **NCT ID:** NCT06747026
- **Lead sponsor:** Fengming Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 338 (ACTUAL)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06747026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06747026, "Real-World Immuno-Radiotherapy for Advanced NSCLC". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06747026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*